ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 627,37
0,74%
Dow Jones
38 775,69
-0,01%
DAX
18 121,29
0,26%
Brent Oil
84,585
0,82%
Bitcoin
64 636,05
-2,78%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Advancis Pharmaceutical (MM) (AVNC)

  7. Advancis Pharmaceutical (MM) (AVNC) Actualités

AVNC

Advancis (AVNC)

Advancis Pharmaceutical (MM)
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:AVNC
DateHeureSourceTitreSymboleSociété
28/06/200714h00PR Newswire (US)Advancis Pharmaceutical Changes Its Name to MiddleBrook Pharmaceuticals, Inc.NASDAQ:AVNCAdvancis Pharmaceutical (MM)
26/06/200720h38PR Newswire (US)Advancis Pharmaceutical Reports on Meeting with FDA Reviewing Keflex PULSYS Phase III Trial DesignNASDAQ:AVNCAdvancis Pharmaceutical (MM)
22/05/200713h55PR Newswire (US)Advancis Pharmaceutical Announces FDA Acceptance of Amoxicillin PULSYS NDANASDAQ:AVNCAdvancis Pharmaceutical (MM)
08/05/200714h00PR Newswire (US)Advancis Pharmaceutical Reports First Quarter 2007 ResultsNASDAQ:AVNCAdvancis Pharmaceutical (MM)
03/05/200715h00PR Newswire (US)Advancis Pharmaceutical to Announce First Quarter 2007 Financial Results on May 8, 2007NASDAQ:AVNCAdvancis Pharmaceutical (MM)
23/04/200721h48PR Newswire (US)Advancis Pharmaceutical Appoints New Board MemberNASDAQ:AVNCAdvancis Pharmaceutical (MM)
18/04/200722h03PR Newswire (US)Advancis Pharmaceutical Closes Private Placement of Common Equity Raising $24 MillionNASDAQ:AVNCAdvancis Pharmaceutical (MM)
09/04/200722h52PR Newswire (US)Advancis Pharmaceutical to Raise $24 Million Through Private Placement of Common EquityNASDAQ:AVNCAdvancis Pharmaceutical (MM)
27/03/200723h30PR Newswire (US)Advancis Pharmaceutical Reports Full Year 2006 Results and 2007 Corporate InitiativesNASDAQ:AVNCAdvancis Pharmaceutical (MM)
23/03/200716h44PR Newswire (US)Advancis Pharmaceutical Resubmits New Drug Application for Once-Daily Amoxicillin PULSYSNASDAQ:AVNCAdvancis Pharmaceutical (MM)
28/02/200712h45PR Newswire (US)Advancis Pharmaceutical Reaches Agreement with FDA for Resubmission of Amoxicillin PULSYS NDANASDAQ:AVNCAdvancis Pharmaceutical (MM)
14/02/200702h15PR Newswire (US)Advancis Pharmaceutical Announces FDA Decision That its Amoxicillin PULSYS NDA is Not CompleteNASDAQ:AVNCAdvancis Pharmaceutical (MM)
12/01/200713h00PR Newswire (US)Advancis Pharmaceutical Announces Preliminary 2006 Product Sales and Year-End Cash PositionNASDAQ:AVNCAdvancis Pharmaceutical (MM)
15/12/200613h00PR Newswire (US)Advancis Pharmaceutical Files New Drug Application For Once-Daily Amoxicillin PULSYSNASDAQ:AVNCAdvancis Pharmaceutical (MM)
14/12/200623h42PR Newswire (US)Advancis Pharmaceutical Closes Private Placement of Common EquityNASDAQ:AVNCAdvancis Pharmaceutical (MM)
11/12/200614h45PR Newswire (US)Advancis Pharmaceutical to Raise $18 Million Through Private Placement of Common EquityNASDAQ:AVNCAdvancis Pharmaceutical (MM)
02/11/200615h20PR Newswire (US)Advancis Pharmaceutical to Present at Rodman and Renshaw 8th Annual Healthcare ConferenceNASDAQ:AVNCAdvancis Pharmaceutical (MM)
01/11/200613h00PR Newswire (US)Advancis Pharmaceutical Reports Third Quarter 2006 ResultsNASDAQ:AVNCAdvancis Pharmaceutical (MM)
31/10/200613h15PR Newswire (US)Advancis Pharmaceutical Submits Proposed Order in Corporate Name Infringement LawsuitNASDAQ:AVNCAdvancis Pharmaceutical (MM)
26/10/200615h00PR Newswire (US)Advancis Pharmaceutical to Announce Third Quarter 2006 Financial Results on November 1, 2006NASDAQ:AVNCAdvancis Pharmaceutical (MM)
24/10/200602h37PR Newswire (US)Advancis Pharmaceutical Announces Promotion of Robert Bannon to Vice President, Investor Relations & Corporate CommunicationsNASDAQ:AVNCAdvancis Pharmaceutical (MM)
23/10/200623h43PR Newswire (US)Advancis Pharmaceutical Announces Promotion of Robert C. Low to Chief Financial OfficerNASDAQ:AVNCAdvancis Pharmaceutical (MM)
13/10/200614h05PR Newswire (US)Advancis Pharmaceutical Provides Update on Keflex LaunchNASDAQ:AVNCAdvancis Pharmaceutical (MM)
28/09/200617h03PR Newswire (US)Advancis Pharmaceutical Receives Judgment in Trademark Infringement LawsuitNASDAQ:AVNCAdvancis Pharmaceutical (MM)
13/09/200614h10PR Newswire (US)Advancis Pharmaceutical On Track to File NDA for Amoxicillin PULSYSNASDAQ:AVNCAdvancis Pharmaceutical (MM)
01/09/200617h26PR Newswire (US)Advancis Pharmaceutical to Present at Thomas Weisel Partners Healthcare ConferenceNASDAQ:AVNCAdvancis Pharmaceutical (MM)
10/08/200619h25PR Newswire (US)Advancis Pharmaceutical Announces Positive Results for Amoxicillin PULSYS Phase III TrialNASDAQ:AVNCAdvancis Pharmaceutical (MM)
02/08/200614h00PR Newswire (US)Advancis Pharmaceutical Reports Second Quarter 2006 ResultsNASDAQ:AVNCAdvancis Pharmaceutical (MM)
26/07/200616h14PR Newswire (US)Advancis Pharmaceutical to Announce Second Quarter 2006 Financial Results on August 2, 2006NASDAQ:AVNCAdvancis Pharmaceutical (MM)
25/07/200614h00PR Newswire (US)Advancis Pharmaceutical Announces Launch of Keflex 750mg CapsulesNASDAQ:AVNCAdvancis Pharmaceutical (MM)
 Showing the most relevant articles for your search:NASDAQ:AVNC

Dernières Valeurs Consultées

SPI
SP500
S&P 500
FTSE
UKX
FTSE 100
EU
MC
Lvmh Moet Hennessy Louis...
EU
BN
Danone
EU
RNO
Renault
NYSE
MCD
McDonalds
EU
SGO
Cie de SaintGobain
EU
ORA
Orange
NASDAQ
GOOGL
Alphabet
EU
BNP
BNP Paribas
NASDAQ
NVDA
NVIDIA
NYSE
JPM
JP Morgan Chase
NYSE
MRK
Merck
USI
USTECH100
US Tech 100
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés